Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.
Pfizer Inc. and BioNTech SE announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use ...
Tag: COVID Countermeasures
Lawmakers Press HSS for Information on Remdesivir Pricing Negotiations with Gilead
Last month, the Food and Drug Administration (FDA) gave its first full approval for a COVID-19 therapeutic to Gilead Sciences' ...
NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates
With multiple promising SARS-CoV-2 vaccine candidates now under development, the National Institute of Allergy and Infectious Diseases (NIAID) is looking ...
New Understanding of Neuropilin-1 Protein Could Speed Pandemic Vaccine Research
When it comes to how the coronavirus invades a cell, it takes three to tango. The dance began with the ...
Meet Ruby the Supercomputer: Now in Service for COVID-19 and Nuclear Security Research
Lawrence Livermore National Laboratory (LLNL), along with partners Intel, Supermicro and Cornelis Networks, have deployed “Ruby,” a high performance computing (HPC) ...
Regeneron Halts Trial for Antibody Cocktail in Sickest COVID-19 Patients
Based on the recommendation of the independent data monitoring committee (IDMC), Regeneron Pharmaceuticals has stopped enrolling patients receiving advanced COVID-19 care ...
New Study Casts Doubt on Benefit of Tocilizumab for Worsening Cases of COVID-19
The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ...
Hydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit
U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers University of Minnesota Medical School physician ...
Building an ACE2 Receptor Trap for Pandemic Pathogens
Researchers led by the University of California, San Francisco and the University of Alberta, Edmonton have engineered angiotensin-converting enzyme II ...
DoD Leverages Lung-on-a-Chip Technology for COVID-19 Research
Military units conduct reconnaissance missions to obtain information – by visual observation or other detection methods – about the activities ...
Centivax Licenses Anti-COVID-19 Antibodies to Thermo Fisher
Centivax Inc, the therapeutics spinout of Contract Research Organization Distributed Bio Inc, announced today a licensing agreement with Thermo Fisher ...
Finding the Golden Window for Collecting COVID-19 Survivor Antibodies
In recovering COVID-19 patients, antibodies fade quickly, but adequate time must be given to clear viral particles before plasma collection ...
Until a Coronavirus Vaccine is Ready, Pneumonia Vaccines May Reduce Deaths from COVID-19
The yearly influenza season threatens to make the COVID-19 pandemic doubly deadly, but I believe that this isn’t inevitable. There ...
SARS, MERS, COVID-19: Repurposing Drugs for a Pan-Coronavirus Treatment
A large international consortium of almost 200 researchers from 14 leading institutions in six countries has studied three different coronaviruses ...
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva
The U.S. Department of Health and Human Services and Department of Defense this week announced an agreement with Cytiva to ...
High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. ...
Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation
In a new study, researchers from the Dangerous Pathogens Team at CSIRO conclude vaccines currently under development for COVID-19 should ...
Eli Lilly Says Antibody Combo Effective Against COVID, Asks for EUA
Eli Lilly and Company today announced additional details on its SARS-CoV-2 neutralizing antibody programs – including interim data on combination therapy ...
How Pharma is Changing to Produce a Pandemic Vaccine in Rapid Time
To bring COVID-19 under control a vaccine needs to be available to every nation, rich and poor – and it ...
The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic
Just like a fresh piece of fish, vaccines are highly perishable products and must be kept at very cold, specific ...
